BriaCell Therapeutics Corp. - Common Shares (NQ:BCTX)

4.040 -0.070 (-1.70%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BriaCell Therapeutics Corp. - Common Shares

< Previous 1 2 3 4 Next >

Which stocks are moving after the closing bell on Wednesday? ↗

April 16, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

BriaCell Stock Rises On Positive Survival Data From Study In Cancer Patients: Retail Gets More Bullish ↗

April 16, 2025

HR+ metastatic breast cancer patients treated with Bria-IMT plus check point inhibitors had a median overall survival of 17.3 months, exceeding the 14.4 months with Trodelvy in similar heavily...

Via Stocktwits

What's going on in today's pre-market session ↗

April 16, 2025

Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Why BriaCell Therapeutics (BCTX) Stock Is Down 40% ↗

December 12, 2024

BriaCell Therapeutics shares are trading lower by 40% Thursday afternoon. The company announced the pricing of a $5.5 million public offering.

Via Benzinga

BriaCell: An Emerging Immuno - Oncology Company ↗

August 14, 2023

BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer.

Via Talk Markets

Biotechs on the Brink: 2 Stocks With Huge Potential

February 14, 2025

BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.

Via MarketBeat

BioMedNewsBreaks — BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) Announces Pricing of $3.05M Public Offering

February 04, 2025

Via Investor Brand Network

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

February 04, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Discover the top movers in Tuesday's pre-market session. ↗

February 04, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket ↗

February 04, 2025

Via Benzinga

Get insights into the top gainers and losers of Monday's after-hours session. ↗

February 03, 2025

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

BriaCell Stock Climbs After ‘Unprecedented’ Immunotherapy Response In Breast Cancer Patient, Retail Exudes Optimism ↗

February 03, 2025

Bria-OTS is a next-generation, personalized advancement of BriaCell’s lead candidate, Bria-IMT, which is currently in a pivotal Phase 3 study for metastatic breast cancer.

Via Stocktwits

Let's take a look at the stocks that are in motion in today's session. ↗

January 29, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Here are the top movers in Wednesday's session. ↗

January 29, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

January 29, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket ↗

January 06, 2025

Via Benzinga

Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2024

Via Benzinga

Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

October 02, 2024

Via Benzinga

Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase ↗

September 11, 2024

Via Benzinga

Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge ↗

September 11, 2024

Via Benzinga

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday ↗

September 11, 2024

BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint inhibitor.

Via Benzinga

Dow Tumbles 350 Points; US Inflation Rate Slows In August ↗

September 11, 2024

Via Benzinga

Topics Economy Stocks

BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024 ↗

June 14, 2024

BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

May 28, 2024

Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

May 21, 2024

Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning!

Via InvestorPlace

BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 ↗

March 19, 2024

BriaCell Therapeutics just reported results for the second quarter of 2024.

Via InvestorPlace

Get Rich Quick With These 3 Penny Stocks to Buy Now ↗

February 12, 2024

Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick.

Via InvestorPlace

Topics Economy

BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients ↗

December 20, 2023

BriaCell Therapeutics Corp (NASDAQ: BCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients...

Via Benzinga

Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023

September 13, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food...

Via FinancialNewsMedia

BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily

May 31, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.